Alibaba and Tencent have reportedly supplied $77m in funding for Baiwang, though the electronic billing software producer has disputed the size of the round.

Chicago’s endowment participated in the series A, following a $1.1m seed round last year that included prize money from the Chicago-run New Venture Challenge.

HTGF has returned to back Freiburg's single cell-dispensing spinout Cytena after previously featuring in the company’s $1.3m round in 2015.

Building on work at MIT’s Koch Institute of Integrative Cancer Research, Elicio hopes to begin patient studies in 2020 for pancreatic, colorectal, head and neck cancers.

Sofinnova Partners and New Enterprise Associates have co-led an oversubscribed series A round for Polyneuron Pharmaceuticals, spun out of University of Basel.

The Y Combinator graduate collected $11.5m in a round that included contributions from Tencent, ServiceNow, Presidio Ventures and GMO Ventures.

TU Berlin spinout IPlytics has collected several million dollars from investors including High-Tech Gründerfonds to expand into the US, South Korea and Japan.

The immunotherapy developer, which is majority owned by BGI Group, has secured $17.8m in a GF Securities-led round that will fund clinical work on its lead product candidate.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Sherlock Biosciences will develop molecular diagnostics tools co-developed by researchers at Harvard University and Broad Institute, including Crispr inventor Feng Zhang.